|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.05 CNY | -2.55% |
|
-2.36% | +60.14% |
| Apr. 15 | Innovita Biological Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 12 | China stocks track Asian markets lower on rate concerns | RE |
Innovita Biological Technology Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 69.5 million compared to CNY 128.99 million a year ago. Net income was CNY 26.35 million compared to CNY 69.09 million a year ago.
Basic earnings per share from continuing operations was CNY 0.26 compared to CNY 0.68 a year ago. Diluted earnings per share from continuing operations was CNY 0.26 compared to CNY 0.68 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +60.14% | 772M | |
| -5.86% | 12.09B | |
| -4.87% | 8.21B | |
| +5.47% | 5.74B | |
| +27.42% | 5.64B | |
| -9.89% | 4.16B | |
| -58.99% | 2.88B | |
| +8.97% | 2.69B | |
| -5.19% | 2.33B | |
| +21.58% | 2.17B |
INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD. 
